Parexel

Parexel, Osaka International Cancer Institute partner in Japan

Monday, August 21, 2017

Parexel International, a global biopharmaceutical services provider, and Osaka International Cancer Institute have formed an alliance to advance clinical development in Japan. The partnership will aim to drive greater efficiencies in support of patient recruitment for clinical trials in oncology and hematology, accelerating the development of innovative and effective new cancer treatments for patients.

[Read More]

Two Parexel executives named to 2017 PharmaVOICE 100

Thursday, August 3, 2017

Parexel International, a global biopharmaceutical services provider, announced that Sy Pretorius, M.D., Senior Vice President and Chief Scientific Officer, and Evan Demestihas, M.D., RPh, Vice President, Worldwide Head of The Medical Affairs Company (TMAC), have been named to PharmaVOICE magazine’s list of the 100 most inspiring people in the life sciences industry. The honor, published in the July/August 2017 issue of PharmaVOICE, recognizes both leaders for their valuable contributions to the industry and dedication to improving patients’ lives, while also mentoring the next generation of industry leaders.

[Read More]

Parexel again named to Forbes America’s Best Employers List

Thursday, June 29, 2017

Parexel International, a global biopharmaceutical services organization, announced that for the second year in a row, Forbes has named the company to its America’s “Best Employers” list. The list recognizes the top 300 midsized employers and top 500 large employers. Results are based on anonymous survey responses from 30,000 U.S. employees, with the most weighted factor being how likely they were to recommend their organizations to others.

[Read More]

QuintilesIMS to buy DrugDev

Monday, June 26, 2017

QuintilesIMS has reportedly reached an agreement to buy DrugDev, a technology company that has built one of the industry’s largest global investigator networks and data sharing platforms, the latest in series of significant mergers among CROs during recent months.   

[Read More]

Parexel launches Connected Journey of newly integrated data-driven services

Monday, June 19, 2017

As life science companies increasingly seek to gain insights from diverse data sources to make drug development more efficient and effective, Parexel International, a global biopharmaceutical services provider, is launching its Connected Journey of data-driven services. This newly integrated network, powered by PAREXEL Analytics capabilities, combines Parexel’s technology, processes and expertise to deliver critical intelligence supporting clinical development and commercialization.  

[Read More]